The 58 references in paper P. Kosareva V., A. Khorinko V., D. Amarantov G., П. Косарева В., А. Хоринко В., Д. Амарантов Г. (2016) “Перспективные направления в изучении патогенеза эмпиемы плевры // Perspective investigations of empyema pathogenesis” / spz:neicon:pulmonology:y:2016:i:3:p:345-351

1
Макаров В.В. Современные аспекты санации плев" ральной полости у больных с острой эмпиемой плевры. Буковинский медицинский вестник.2008; 12 (3): 39–41. / Makarov V.V. Current aspects of pleural draining in acute empyema. Bukovinskiy meditsinskiy vestnik 2008; 12 (3): 39–41 (in Russian).
(check this in PDF content)
2
Дударев А.А., Сухоруков А.М., Большаков В.Н. и др. Оценка гемостазиологических сдвигов у больных с ост" рой неспецифической эмпиемой плевры. В кн.: Мате" риалы III Съезда хирургов Сибири и Дальнего Востока. Томск; 2009: 86–87. / Dudarev A.A., Sukhorukov A.M., Bol'shakov V.N. et al. Haemostatic change in patients with acute non"specific empyema. In: Proceedings of the 3rd Congress of Surgeons of Syberia and the Far East. Tomsk; 2009: 86–87 (in Russian).
(check this in PDF content)
3
Никольский В.И., Логинов С.Н., Баженов М.С., Семи" саженов О.А. Динамическая торакоскопия с примене" нием торакопорта в лечении больных с неспецифичес" кой эмпиемой плевры. Известия высших учебных заве# дений.Поволжский регион. 2010; 4 (16): 99–107. / Nikol'skiy V.I., Loginov S.N., Bazhenov M.S., Semisa" zhenov O.A. Dynamic thoracoscopy in patients with acute non"specific empyema using thoracoport. Izvestiya vysshikh uchebnykh zavedeniy.Povolzhskiy region. 2010; 4 (16): 99–107 (in Russian).
(check this in PDF content)
4
Lee S.F., Lawrence D., Booth H. et al. Thoracic empyema: current opinions in medical and surgical management.Curr. Opin. Pulm. Med.2010; 16 (3): 194–200.
(check this in PDF content)
5
Черкасов В.А., Хусейн Х.С. Лечение больных эмпие" мой плевры.Пермский медицинский журнал. 2009; 26 (2): 15–19. / Cherkasov V.A., Khuseyn Kh.S. Treatment of patients with empyema.Permskiy meditsinskiy zhurnal 2009; 26 (2): 15–19 (in Russian).
(check this in PDF content)
6
Проценко А.В. Выбор способа торакопластики при бронхиальном свище и эмпиеме плевры после пуль" монэктомии. Анналы хирургии.2009; 2: 40–42. / Protsen" ko A.V. A choice of thoracoplastics method in post"pneu" monectomy bronchial fistula and empyema. Annaly khirur# gii 2009; 2: 40–42 (in Russian).
(check this in PDF content)
7
Dudarev А.А., Sukhorukov А.М., Bolshakov V.N. et al. Use of thoracoscopy in local treatment of nonspecific pleural empyema.Bull. Intern. Sci. Surg. Ass.2010; 5 (1): 11–12.
(check this in PDF content)
8
Cheah Y.L., Ng T., Shah K. et al. Video"assisted Thoraco" scopic Surgery (VATS) drainage of salmonella enteritidis empyema and needle"localization for retrieval of a dropped gallstone. Surg. Laparosc. Endosc. Percutan. Tech. 2010; 20 (4): 265–268.
(check this in PDF content)
9
Лукомский Г.И. Неспецифические эмпиемы плевры. М.: Медицина; 1976. / Lukomskiy G.I. Non"specific em" pyema. Moscow: Meditsina; 1976 (in Russian).
(check this in PDF content)
10
Capelozzi V.L., da Rosa D.C., da Silva A.S.F. The value of cytology and pleural biopsy in the differential diagnostic of nonspecific pleural effusions. J. Pneumol.2003; 29 (4): 225–234. On"line version: http://dx.doi.org/10.1590/S0102# 35862003000400012.
(check this in PDF content)
11
Olgac G., Fazlioglu M., Kutlu C.A. VATS decortication in patients with stage 3 empyema. Thorac. Cardiovasc. Surg. 2005; 53 (5): 318–320.
(check this in PDF content)
12
Vyhnánek F., Fanta J., Jirava D., Ocadlík M. Contemporary approach to treatment of the posttraumatic empyema of the thorax. Rozhl. Chir. 2006; 85 (1): 4–8.
(check this in PDF content)
13
Koh D."M., Burke S., Davies N., Padley S.P.G. Trans" thoracic US of the chest: clinical uses and applications. RadioGraphics.2002; 22 (1): e1. DOI: http://dx.doi.org/ 10.1148/radiographics.22.1.g02jae1e1.
(check this in PDF content)
14
Andrews N.C., Parker E.F., Shaw R.R. et al. Management of nontuberculous empyema.Am. Rev. Respir. Dis.1962; 85: 935–936.
(check this in PDF content)
15
Вагнер Е.А., Перепелицын В.Н., Субботин В.М. и др. Эндоскопическая окклюзия культи главного бронха при ее несостоятельности. Грудная и сердечно#сосудис# тая хирургия.1990; 2: 46–49. / Vagner E.A., Perepelitsyn V.N., Subbotin V.M.et al. Endoscopic occlusion of the main bronchus cuff in a case of its failure. Grudnaya i serdechno# sosudistaya khirurgiya1990; 2: 46–49 (in Russian).
(check this in PDF content)
16
Light R.W. Parapneumonic effusions and empyema. Proc. Am. Thorac. Soc.2006; 3 (1): 75–80.
(check this in PDF content)
17
Порханов В.А., Коровин А.Я. Новые возможности ле" чения постпневмонэктомической острой эмпиемы плевры со свищами главных бронхов: В кн.: Материа" лы III Конгресса ассоциации хирургов им. Н.И.Пиро" гова. М.; 2001: 122–124. / Porkhanov V.A., Korovin A.Ya. Косарева П.В. и др. Перспективные направления в изучении патогенеза эмпиемы плевры Novel approaches to treatment of acute post"pneumonecto" my empyema and bronchial fistula of the main bronchus. In: Proceedings of the 3rdCongress of N.I.Pirogov Associa" tion of Surgeons. Moscow; 2001: 122–124 (in Russian).
(check this in PDF content)
18
Decologne N., Kolb M., Margetts P.J. et al. TGF"β1induces progressive pleural scarring and subpleural fibrosis. J. Immunol.2007; 179 (9): 6043–6051.
(check this in PDF content)
19
Owens S., Jeffers A., Boren J. et al. Mesomesenchymal transition of pleural mesothelial cells is PI3K and NF"κB dependent.Am. J. Physiol. Lung Cell. Mol. Physiol.2015; 308 (12): 1265–1273.
(check this in PDF content)
20
Heldin C."H., Miyazono K., Dijke P. TGF"b signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997; 390: 465–471.
(check this in PDF content)
21
Chena L."J., Yeb H., Zhanga Q. et al. Bleomycin induced epithelial"mesenchymal transition (EMT) in pleural meso" thelial cells.Toxicol. Appl. Pharmacol. 2015; 283 (2): 75–82.
(check this in PDF content)
22
Mutsaers S.E., Birnie K., Lansley S. et al. Mesothelial cells in tissue repair and fibrosis.Front. Pharmacol. 2015; 6: 113.
(check this in PDF content)
23
Lee Y.C., Malkerneker D., Devin C.J. et al. Comparing transforming growth factor β"2 and fibronectin as pleu" rodesing agents. Respirology. 2001; 6: 281–286.
(check this in PDF content)
24
Lee Y.C., Lane K.B., Zoia O. et al. Transforming growth factor"b induces collagen synthesis without inducing IL"8 production in mesothelial cells. Eur. J. Respir. 2003; 22: 197–202.
(check this in PDF content)
25
Kunz C.R., Jadus M.R., Kukes G.D. et al. Intrapleural injec" tion of transforming growth factor"[beta] antibody inhibits pleural fibrosis in empyema. Laboratory and animal inves" tigations. Chest. 2004; 126 (5): 1636–1644. http:// business.highbeam.com/137522/article#1G1#125648645/ intrapleural#injection#transforming#growth#factorbeta
(check this in PDF content)
26
Qing"qing Z., Geng"Yun S. Transforming growth factor"β and pleural fibrosis. Intern. J. Respir. 2009; 29 (10): 609–612.
(check this in PDF content)
27
Leask A. Signaling in fibrosis: targeting the TGF beta, endothelin"1 and CCN2 axis in scleroderma. Front. Biosci. 2009; 1: 115–122.
(check this in PDF content)
28
Итмезех А. Механизмы формирования пневмосклеро" за при хроническом эндотоксикозе (эксперименталь" ное исследование): Дисс. ... канд. мед. наук. Волгоград; 2006. / Itmezekh A. Mechanisms of the lung tissue fibrosis in chronic endotoxicosis: Diss. Volgograd; 2006 (in Russian).
(check this in PDF content)
29
Xaubet A., Marin"Arguedas A., Lario S. et al. Transforming growth factor"beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.2003; 168: 431–435.
(check this in PDF content)
30
Lawson W.E., Crossno P.F., Polosukhin V.V. et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant pro" tein processing and herpesvirus infection. Am. J. Physiol. Lung Cell. Mol. Physiol.2008; 294: 1119–1126.
(check this in PDF content)
31
Datta A., Scotton C.J., Chambers R.C. Novel therapeutic approaches for pulmonary fibrosis Pulmonary fibrosis. Br. J. Pharmacol. 2011; 163: 141–172.
(check this in PDF content)
32
Moore B.B., Murray L., Das A. et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis.Am. J. Respir. Cell. Mol. Biol. 2006; 35: 175–181.
(check this in PDF content)
33
Mehrad B., Burdick M.D., Strieter R.M. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int. J. Biochem. Cell. Biol. 2009; 41: 1708–1718.
(check this in PDF content)
34
Batra H., Antony V.B. Pleural mesothelial cells in pleural and lung diseases. J. Thorac. Dis. 2015; 7 (6): 961–963. http:// www.jthoracdis.com/article/view/4274/html
(check this in PDF content)
35
Scotton C.J., Chambers R.C. Molecular targets in pul" monary fibrosis: the myofibroblast in focus. Chest. 2007; 132: 1311–1321.
(check this in PDF content)
36
Moodley Y.P., Scaffidi A.K., Misso N.L. et al. Fibroblasts isolated from normal lungs and those with idiopathic pul" monary fibrosis differ in interleukin"6/gp130"mediated cell signaling and proliferation.Am. J. Pathol. 2003; 163: 345–354.
(check this in PDF content)
37
Moodley Y.P., Caterina P., Scaffidi A.K. et al. Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL" induced apoptosis. J. Pathol.2004; 202: 486–495.
(check this in PDF content)
38
Kogan E., Тuong V., Demoura S. Mechanism of bron" choalveolar duct junction (BADJ) remodeling in idiopathic pulmonary fibrosis (IPF) as base for new pathogenetic ther" apy. Eur. Respir. J. 2008; 32 (Suppl. 52): 3489.
(check this in PDF content)
39
Tuong V., Demoura S., Kogan E. Markers of cell prolifera" tion, apoptosis and angiogenesis in remodeling of bron" choalveolar duct junctions. Polish Histochemichal et Cytological Society. Folia Histochemica et Cytobiologica. 2008; 46 (2): 68.
(check this in PDF content)
40
Scotton C.J., Krupiczojc M.A., Konigshoff M. et al. Increased local expression of coagulation factor X con" tributes to the fibrotic response in human and murine lung injury. J. Clin. Invest.2009; 119: 2550–2563.
(check this in PDF content)
41
Scotton C.J., Chambers R.C. Pulmonary fibrosis. Br. J. Pharmacol.2011; 163: 141–172.
(check this in PDF content)
42
Sun Z."M., Li F."Y., Wang L. et al. Expression of fibroblast specific protein"1 in pleural tuberculosis and its clinical bio" logical significance.World J. Surg. Oncol.2014; 12: 151.
(check this in PDF content)
43
Miles S.E., Sandrini A., Johnson A.R., Yates D.H. Clinical consequences of asbestos"related diffuse pleural thickening: A review.J. Occup. Med. Toxicol. 2008; 3: 1–10.
(check this in PDF content)
44
Huang S.X.L., Jaurand M."C., Kamp D.W. et al. Role of Mutagenicity in asbestos fiber"induced carcinogenicity and other diseases.J. Toxicol. Environment. Health. Part B. Crit. Rev. 2011; 14 (1–4): 179–245.
(check this in PDF content)
45
Broaddus V.C., Everitt J.I., Black B., Kane A.B. Non"neo" plastic and neoplastic pleural endpoints following fiber exposure. J. Toxicol. Environ. Health. Part B.Crit. Rev. 2011; 14 (1–4): 153–178.
(check this in PDF content)
46
Sasse S.A., Jadus M.R., Kukes G.D. Pleural fluid trans" forming growth factor"β1correlates with pleural fibrosis in experimental empyema.Am. J. Respir. Crit. Care Med. 2003; 168: 700–705.
(check this in PDF content)
47
Papaioannou A.I., Kostikas K., Kollia P., Gourgoulianis K.I. Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir. Res. 2006; 7: 128.
(check this in PDF content)
48
Compernolle V., Brusselmans K., Acker T. et al. Loss of HIF"2alpha and inhibition of VEGF impair fetal lung mat" uration, whereas treatment with VEGF prevents fatal respi" ratory distress in premature mice. Nat. Med. 2002; 8 (7): 702–710.
(check this in PDF content)
49
Kazi A.S., Lotfi S., Goncharova E.A. et al. Vascular endothelial growth factor"induced secretion of fibronectin is ERK dependent. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 286 (3): 539–545.
(check this in PDF content)
50
Mura M., dos Santos C.C., Stewart D., Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. J. Appl. Physiol.2004; 97 (5): 1605–1617.
(check this in PDF content)
51
Grove C.S., Lee Y.C. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr. Opin. Pulm. Med. 2002; 8 (4): 294–301.
(check this in PDF content)
52
Mohammed K.A., Nasreen N., Hardwick J. et al. Bacterial induction of pleural mesothelial monolayer barrier dysfunc" tion. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001; 281 (1): 119–125.
(check this in PDF content)
53
Humadi H.Y.A. Matrix Metalloproteinases and TIMPs Expression in Pleural Effusion of Different Origins. Thesis submitted for fulfillment of Master Degree in Pulmonology. Faculty of Medicine Cairo University; 2012.
(check this in PDF content)
54
Oikonomidi S., Kostikas K., Kalomenidis I. et al. Matrix metalloproteinase levels in the differentiation of parapneu" monic pleural effusions. Respiration. 2010; 80: 285–291.
(check this in PDF content)
55
El Margoushya N.M., Khaleel A.T. Metalloproteinase and tissue inhibitor of metalloproteinase in tuberculosis and malignant pleural effusion.Egypt. J. Chest Dis. Tub. 2013; 62 (2): 235–240.
(check this in PDF content)
56
Yamashita C.M., Dolgonos L., Zemans R.L. et al. Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis. Am. J. Pathol.2011; 179( 4): 1733–1745.
(check this in PDF content)
57
Kim J.Y., Choeng H.C., Ahn C. Cho S."H. Early and late changes of MMP"2 and MMP"9 in bleomycin"induced pul" monary fibrosis. Yonsei Med. J. 2009; 50 (1): 68–77.
(check this in PDF content)
58
Sheen P., O’Kane C.M., Chaudhary K. et al. High MMP"9 activity characterises pleural tuberculosis correlating with granuloma formation.Eur. Respir. J.2009; 33 (1): 134–141. Поступила 04.03.16 УДК 616.256002.36092
(check this in PDF content)